46 related articles for article (PubMed ID: 2528741)
1. Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer.
Brogden RN; Chrisp P
Drugs Aging; 1991 Mar; 1(2):104-15. PubMed ID: 1794008
[TBL] [Abstract][Full Text] [Related]
2. [A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
Schmeller N
Internist (Berl); 1992 Apr; 33(4):284. PubMed ID: 1535344
[No Abstract] [Full Text] [Related]
3. Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Di Silverio F; Sciarra F; D'Eramo G
Eur Urol; 1990; 18(1):10-5. PubMed ID: 2144819
[TBL] [Abstract][Full Text] [Related]
4. Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
Waxman J
Prog Clin Biol Res; 1989; 303():61-8. PubMed ID: 2528741
[No Abstract] [Full Text] [Related]
5. Cyproterone acetate in the management of prostatic cancer.
Tunn UW
Prog Clin Biol Res; 1989; 303():105-10. PubMed ID: 2528734
[No Abstract] [Full Text] [Related]
6. Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate-type in the treatment of prostatic cancer.
Habenicht UF; Schröder H; el Etreby MF; Neumann F
Prog Clin Biol Res; 1988; 260():63-75. PubMed ID: 2966407
[No Abstract] [Full Text] [Related]
7. Initiation of LHRH monotherapy for prostate cancer.
Milsted RA
Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
[No Abstract] [Full Text] [Related]
8. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Jacobi GH; Wenderoth UK
Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
[No Abstract] [Full Text] [Related]
9. Cancer of the prostate. Mechanisms of action of antiandrogens.
Habenicht UF; Neumann F; el Etreby MF
Acta Urol Belg; 1991; 59(4):1-10. PubMed ID: 1840231
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]